Smell Regions in Patients with Vitamin D Deficiency: An MRI Evaluation.
Ziya ŞencanNuray Bayar MulukMehmet Hamdi ŞahanPublished in: Journal of neurological surgery. Part B, Skull base (2021)
Objective We investigated the effects of vitamin D deficiency in the peripheral and central smell regions by magnetic resonance imaging (MRI). Methods This retrospective study included 29 patients (12 males, 17 females) with 25-dihydroxy vitamin D3 [25(OH) 2 D 3 ] deficiency (group 1) and 34 subjects without 25(OH) 2 D 3 deficiency (14 males, 20 females) (group 2). Using cranial MRIs, the peripheral (olfactory bulb [OB] volume and olfactory sulcus [OS] depth) and central (insular gyrus and corpus amygdala) smell regions were evaluated. Results The OB volume and OS depth values of the 25(OH) 2 D3 deficiency group were significantly lower than those of the control group ( p < 0.05). For the central smell regions, the insular gyrus and corpus amygdala areas of the 25(OH) 2 D3 deficiency group were nonsignificantly lower than those in the control group ( p > 0.05). There were positive correlations between OB volumes, OS depths, and insular gyrus and corpus amygdala areas bilaterally in the 25(OH) 2 D3 deficiency group separately and in all subjects (groups 1 and 2) ( p < 0.05). In the 25(OH) 2 D3 deficiency group, as the 25(OH) 2 D3 values became lower, the insular gyrus area values decreased bilaterally ( p < 0.05). In females, the corpus amygdala area values were lower than in males ( p < 0.05). Conclusion Since vitamin D3 deficiency affected the peripheral and central smell regions negatively, we recommend evaluating patients' vitamin D levels as a health policy to prevent vitamin D3 deficiency-related cranial smell region problems. Moreover, sunlight exposure is very important to increase vitamin D levels, and the public should be informed about this topic.
Keyphrases
- magnetic resonance imaging
- end stage renal disease
- healthcare
- mental health
- functional connectivity
- public health
- ejection fraction
- chronic kidney disease
- newly diagnosed
- replacement therapy
- contrast enhanced
- resting state
- prognostic factors
- emergency department
- patient reported outcomes
- peritoneal dialysis
- prefrontal cortex
- mass spectrometry
- risk assessment
- diffusion weighted imaging